Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Yahoo/MarketWire
Sat, 08/4/12 - 11:22 am
Tags:
Medivation, Astellas, Enzalutamide, prostate cancer
Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA
Yahoo/Fly on the Wall
Tue, 07/24/12 - 09:41 am
Tags:
Enzalutamide, Medivation, Astellas, prostate cancer
Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Bloomberg
Mon, 07/16/12 - 08:48 am
Tags:
prostate cancer, Medivation, M&A, AbbVie, Astellas, Enzalutamide
Astellas Bladder Treatment Wins U.S. Approval For Sale
Bloomberg
Thu, 06/28/12 - 06:04 pm
Tags:
Astellas, FDA, overactive bladder, mirabegron
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Thu, 05/31/12 - 10:17 am
Tags:
Medivation, prostate cancer, MDV3100, Astellas
Medivation Files Enzalutamide NDA
Yahoo/Zacks
Tue, 05/22/12 - 11:16 am
Tags:
Medivation, Astellas, prostate cancer, Enzalutamide
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
Tags:
BB1608, Boston Biomedical, Dainippon Sumitomo, cabozantinib, Exelixis, ONYX Pharmaceuticals, Carfilzomib, Medivation, Astellas, Enzalutamide, Ariad Pharmaceuticals, Ponatinib, Bayer, regorafenib, Oncovex, Amgen, Roche, Genentech, T-DM1, Immunogen, Aveo, tivozanib, Zaltrap, Sanofi, Regeneron
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Bloomberg
Thu, 04/5/12 - 09:07 pm
Tags:
FDA, overactive bladder, Astellas, mirabegron
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Bloomberg
Tue, 04/3/12 - 08:54 am
Tags:
Astellas, overactive bladder, FDA, mirabegron
New Data Demonstrates DIFICLIR™ May Offer Benefits for Cancer Patients, who are at High Risk of Clostridium Difficile Infection
Sacramento Bee, CA
Sat, 03/31/12 - 01:03 pm
Tags:
Dificid, Clostridium Difficile, Astellas
Astellas extends deal to sell Pfizer's Lipitor in Japan
Reuters
Thu, 03/29/12 - 10:02 am
Tags:
Pfizer, Lipitor, statins, Japan, Astellas
Cardiome Investors: Why Shares Crashed 50%
Motley Fool
Tue, 03/20/12 - 10:02 am
Tags:
Cardiome, Merck, Astellas, Vernakalant
Biotech Stocks To Watch In 2012
Seeking Alpha
Mon, 02/6/12 - 11:20 am
Tags:
Astellas, Array Biopharma, AstraZeneca, Celldex, Exelixis, Pfizer, Progenics Pharmaceuticals, Seattle Genetics, Synta
IPO Preview: Verastem
Seeking Alpha
Wed, 01/25/12 - 12:36 pm
Tags:
IPOs, Verastem, Astellas, GSK, Pfizer, Sanofi
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Yahoo/MarketWire
Sat, 01/7/12 - 01:25 pm
Tags:
Theravance, Astellas, Vibativ, antibiotics
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Tue, 01/3/12 - 11:31 am
Tags:
Aveo Pharmaceutical, Astellas, renal cell carcinoma, tivozanib
Zogenix, Astellas to end co-promotion for migraine injection
Reuters
Wed, 12/21/11 - 08:35 am
Tags:
Astellas, Zogenix, migraines, Sumavel DosePro
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
Fri, 11/11/11 - 01:04 pm
Tags:
FDA, EMA, overactive bladder, Astellas, mirabegron
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tue, 10/25/11 - 10:49 am
Tags:
pancreatic cancer, Amgen, Celgene, Infinity, Oncolytics, Pharmacyclics, Immunomedics, Threshold Pharmaceuticals, Clovis Oncology, Novartis, Aduro BioTech, NewLink Genetics, Seattle Genetics, Bayer Schering, Astellas
Astellas halts development of anti-clotting drug
Reuters
Wed, 09/28/11 - 09:19 am
Tags:
Astellas, YM150, anti-clotting

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.